21 research outputs found

    A commensal strain of Staphylococcus epidermidis protects against skin neoplasia.

    Get PDF
    We report the discovery that strains of Staphylococcus epidermidis produce 6-N-hydroxyaminopurine (6-HAP), a molecule that inhibits DNA polymerase activity. In culture, 6-HAP selectively inhibited proliferation of tumor lines but did not inhibit primary keratinocytes. Resistance to 6-HAP was associated with the expression of mitochondrial amidoxime reducing components, enzymes that were not observed in cells sensitive to this compound. Intravenous injection of 6-HAP in mice suppressed the growth of B16F10 melanoma without evidence of systemic toxicity. Colonization of mice with an S. epidermidis strain producing 6-HAP reduced the incidence of ultraviolet-induced tumors compared to mice colonized by a control strain that did not produce 6-HAP. S. epidermidis strains producing 6-HAP were found in the metagenome from multiple healthy human subjects, suggesting that the microbiome of some individuals may confer protection against skin cancer. These findings show a new role for skin commensal bacteria in host defense. Sci Adv 2018 Feb 28; 4(2):eaao450

    Structure-based design and synthesis of antiparasitic pyrrolopyrimidines targeting pteridine reductase 1

    Get PDF
    The treatment of Human African Trypanosomiasis remains a major unmet health need in sub-Saharan Africa. Approaches involving new molecular targets are important and pteridine reductase 1 (PTR1), an enzyme that reduces dihydrobiopterin in Trypanosoma spp. has been identified as a candidate target and it has been shown previously that substituted pyrrolo[2,3-d]pyrimidines are inhibitors of PTR1 from T. brucei (J. Med. Chem. 2010, 53, 221-229). In this study, 61 new pyrrolo[2,3-d]pyrimidines have been prepared, designed with input from new crystal structures of 23 of these compounds complexed with PTR1, and evaluated in screens for enzyme inhibitory activity against PTR1 and in vitro antitrypanosomal activity. 8 compounds were sufficiently active in both screens to take forward to in vivo evaluation. Thus although evidence for trypanocidal activity in a stage I disease model in mice was obtained, the compounds were too toxic to mice for further development

    Preparation of a `Si-centered' chiral auxiliary by resolution

    Full text link
    (R)- and (S)-[(benzyloxy)methyl](tert-butyl)methylsilane [(−)-(R)-1 and (+)-(S)-1], possessing a stereogenic center at the Si-atom, were prepared in highly enantiomerically enriched form by resolution via diastereomeric silyl ethers. Conversion of the hydrosilanes into different functionalized chiral silanes by direct or stepwise substitution of the (Si)–H-atom was shown to proceed with high stereoselectivity (96–98% stereoselectivity under optimized conditions) thus allowing the preparation of substrates where the chiral silicon moiety can act as a chiral auxiliary for stereoselective transformations

    More than a protective group: synthesis and applications of a new chiral silane

    Full text link
    Enantiomerically pure (-)-(R)- and (+)-(S)-(1-methoxy-2,2,2-triphenylethyl)dimethylsilanes (MOTES-H) were synthesized from triphenylacetaldehyde in five synthetic steps and with 60% overall yield. MOTES-protected alpha- and beta-hydroxycarbonyl compounds were used in Grignard and Diels-Alder reactions in the presence of MgBr2 to afford addition products with 87-98% yield and selectivities of up to >120:1 dr. With this method, the pine beetle pheromone (-)-frontalin (67%, 98.5% ee) and naturally occurring (-)-(R)-octane-1,3-diol (90%, >99% ee) were synthesized
    corecore